Lyra Therapeutics, Inc. (LYRA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $46.83M | -14.5% |
| 2024 | $54.75M | +3.0% |
| 2023 | $53.18M | +82.0% |
| 2022 | $29.21M | +42.2% |
| 2021 | $20.55M | +224.3% |
| 2020 | $6.34M | -17.0% |
| 2019 | $7.63M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $46.83M | -14.5% |
| 2024 | $54.75M | +3.0% |
| 2023 | $53.18M | +82.0% |
| 2022 | $29.21M | +42.2% |
| 2021 | $20.55M | +224.3% |
| 2020 | $6.34M | -17.0% |
| 2019 | $7.63M | — |